(Q42553000)

2 November 2017

Combinatorial drug screening identifies synergistic co-targeting of Bruton's tyrosine kinase and the proteasome in mantle cell lymphoma (English)

1 reference

2 November 2017

0 references

M Axelrod

1

1 reference

2 November 2017

Z Ou

2

1 reference

2 November 2017

L K Brett

3

1 reference

2 November 2017

L Zhang

4

1 reference

2 November 2017

E R Lopez

5

1 reference

2 November 2017

A T Tamayo

6

1 reference

2 November 2017

V Gordon

7

1 reference

2 November 2017

R J Ford

8

1 reference

2 November 2017

M E Williams

9

1 reference

2 November 2017

L V Pham

10

1 reference

2 November 2017

M J Weber

11

1 reference

2 November 2017

M L Wang

12

1 reference

2 November 2017

27 August 2013

1 reference

2 November 2017

1 reference

2 November 2017

28

1 reference

2 November 2017

2

1 reference

2 November 2017

407-410

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2013.249

2 November 2017

0 references

cites work

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918872

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918872

The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918872

Circumventing cancer drug resistance in the era of personalized medicine

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918872

Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918872

Compensatory pathways induced by MEK inhibition are effective drug targets for combination therapy against castration-resistant prostate cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918872

Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918872

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918872

Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918872

From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918872

KEGG: kyoto encyclopedia of genes and genomes

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918872

A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918872

16 August 2018

Identifiers

DOI

10.1038/LEU.2013.249

1 reference

Dimensions Publication ID

2 November 2017

0 references

1 reference

2 November 2017

PubMed publication ID

23979520

1 reference